Sign Out
Claritrox 250 mg Tablet: Pregnancy: There are no adequate and well-controlled studies in pregnant women. Clarithromycin should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.
Breast Feeding: Clarithromycin and its active metabolite are distributed into human breast milk. Therefore, caution should be exercised when clarithromycin is administered to a nursing woman.
Metgyl 400 mg Tablet: Pregnancy / Reproduction: Studies in rats have not shown that metronidazole cause impaired fertility or birth defect in the fetus. When administered orally, no foeto-toxicity was seen in pregnant mice. However, the use of metronidazole in the treatment of trichomoniasis is not recommended during the first trimester.
Breast-feeding: Use is not recommended in nursing mothers. During treatment with metronidazole, the breast milk should be expressed and discarded. Breast-feeding may be resumed 24 to 48 hours after treatment is completed.
Omilock 20 mg Capsule: Pregnancy: Adequate and well-controlled studies in humans have not been done and the drug is not recommended.
Breast-feeding: It is not known whether omeprazole is distributed into human breast milk. However, because omeprazole has been shown to cause tumorigenic and carcinogenic effects in animals, a decision should be made on whether nursing should be discontinued or the medication withdrawn, taking into account the importance of the omeprazole to the mother.
